Related Experiment Videos
[Sarcomas of soft tissue in the adult. Therapeutical indications]
1Fondation Bergonié, Bordeaux, France.
Abstract:
Treatment of soft-tissue sarcomas has to deal simultaneously with three goals: 1) to obtain the control of the primary tumor, 2) to preserve the function, and 3) to treat the micrometastatic disease. For local control, surgery remains the most efficient treatment, but the extent of the resection of macroscopically non-involved tissue, and as consequence, resulting dysfunction, can be reduced by properly planned postoperative radiotherapy and chemotherapy. Moreover, surgery may be easier, following preoperative radiotherapy or chemotherapy, which may also allow secondary excision of a primarily inoperable tumor. For the treatment of the micrometastatic disease, the efficacy of adjuvant chemotherapy has to be confirmed by further studies; some results published to date are encouraging. Thus, treatment of soft-tissue sarcomas remains difficult, but important advances are to be expected in the next few years. A multidisciplinary approach is necessary, involving not only surgeons, radiotherapists and medical oncologists, but also radiologists and pathologists.
Insights
Effective soft-tissue sarcoma treatment requires controlling the primary tumor, preserving function, and managing micrometastatic disease. Advances in multimodal therapies, including surgery, radiotherapy, and chemotherapy, are crucial for improved patient outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Oncology
Context:
- Soft-tissue sarcomas present complex treatment challenges.
- Balancing tumor control, functional preservation, and micrometastatic disease management is critical.
Purpose:
- To outline the multifaceted goals in treating soft-tissue sarcomas.
- To discuss the roles of surgery, radiotherapy, and chemotherapy in achieving these goals.
Summary:
- Surgery is primary for local control, but its extent and functional impact can be mitigated by planned radiotherapy and chemotherapy.
- Preoperative therapies may facilitate surgery and enable treatment of initially inoperable tumors.
- Adjuvant chemotherapy shows promise for micrometastatic disease, though further validation is needed.
Impact:
- Multidisciplinary collaboration among surgeons, radiotherapists, medical oncologists, radiologists, and pathologists is essential.
- Ongoing research and advances are expected to improve soft-tissue sarcoma treatment strategies.
- Optimizing treatment protocols aims to enhance tumor control and functional outcomes.